Observation on the effect of Xuezhikang in decreasing the adverse cardiovascular and cerebrovascular events of patients with normal blood lipid and cerebral infarction
Objective To study the effect of Xuezhikang in decreasing the adverse cardiovascular and cerebrovascular events of patients with normal blood lipid and cerebral infarction. Methods 300 patients with normal blood lipid and cerebral infarction from January 2010 to December 2010 were selected as research object,and they were randomly divided into group A(routine treatment group) 100 cases,group B(atorvastatin group) 100 cases and group C(Xuezhikang group) 100 cases, then the adverse cardiovascular and cerebrovascular events rate, adverse reaction rate and carotid artery intima-media thickness, serum CK, CK-MB, AST, ALT before and after the intervention of two groups were compared. Results The adverse cardiovascular and cerebrovascular events rate of group B and group C were both lower than that of group A, serum CK and CK-MB after the intervention were lower than those of group A, carotid artery intima-media thickness were better than those of group A, and adverse reaction rate of group C was lower than that of group B, all P<0.05, there were all significant differences, while the serum AST and ALT of three groups had no significant differences, all P>0.05. Conclusion The effect of Xuezhikang in decreasing the adverse cardiovascular and cerebrovascular events of patients with normal blood lipid and cerebral infarction is better, and it can effectively decrease the vascular risk degree.
XuezhikangNormal blood lipidCerebral infarctionAdverse cardiovascular and cerebrovascular eventsEffect
NETL
NSTL
万方数据
维普
